Both CD4 and CD8 PPI-responsive TCRβs accumulated throughout the preclinical period of T1D development, while reactivities to GAD and ZnT8 were present in similar numbers early in life but remained persistent in cases while declining in controls. This evidence concerns the gene CD8A and type 1 diabetes mellitus.